SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-143173
Filing Date
2019-05-09
Accepted
2019-05-09 17:16:06
Documents
11
Period of Report
2019-05-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d689955d8k.htm 8-K 50528
2 EX-3.1 d689955dex31.htm EX-3.1 77215
3 EX-4.2 d689955dex42.htm EX-4.2 99242
4 EX-10.1 d689955dex101.htm EX-10.1 249887
5 EX-10.2 d689955dex102.htm EX-10.2 220556
6 EX-99.1 d689955dex991.htm EX-99.1 11963
7 EX-99.2 d689955dex992.htm EX-99.2 7665
8 EX-99.3 d689955dex993.htm EX-99.3 8851
9 EX-99.4 d689955dex994.htm EX-99.4 40923
10 GRAPHIC g689955g0508195234158.jpg GRAPHIC 6954
11 GRAPHIC g689955g0509105637842.jpg GRAPHIC 2596
  Complete submission text file 0001193125-19-143173.txt   781709
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 100 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 19811780
SIC: 2834 Pharmaceutical Preparations